Last updated: November 11, 2026
Can blue light ease eczema itch or help a psoriasis plaque fade? In a sham-controlled eczema trial, people who received 450 nm light reported less itch, while clinician-rated eczema severity showed no significant improvement. For mild plaque psoriasis, some studies found improvements in individual treated patches. [1] [2]
What blue light does in inflamed skin
What blue light actually does to inflamed skin
Blue light is visible light. In skin, it is absorbed more superficially than red light under comparable conditions. Its effects vary with the wavelength, exposure, and molecules that absorb it. For example, porphyrins produced by Cutibacterium acnes can absorb blue light, which helps explain why researchers study it for acne. Eczema and psoriasis studies ask different questions, such as whether itch eases or plaques get thinner. [3]
Laboratory researchers have also looked at how blue light affects keratinocytes, the main cells in the outer layer of skin. Some experiments found slower cell growth, a finding of interest in psoriasis because these cells multiply faster in plaques. A 2026 review of 44 cell-culture studies found responses ranging from changes in cell signaling to oxidative stress and reduced cell viability. [4]
What clinical studies found for eczema and psoriasis
How blue light therapy works for psoriasis and eczema specifically
Atopic dermatitis and eczema itch
The 2023 AD-Blue trial enrolled 87 adults with atopic dermatitis and analyzed clinical outcomes in 73. It compared eight weeks of full-body 415 nm or 450 nm light with sham treatment. Neither wavelength significantly improved the primary outcome, the Eczema Area and Severity Index (EASI), compared with sham. Itch was a secondary outcome. On a 0–10 scale, average itch fell by 1.6 points with 450 nm light and rose by 0.1 points with sham. The 415 nm group improved on a patient-reported eczema score, while the clinician-rated SCORAD score showed no significant advantage over sham. [1]
Smaller studies looked at different settings. In one four-week study, 20 people completed a comparison of matched eczema patches on opposite sides of the body. The local severity score fell by 1.9 points at sites treated with 453 nm light and by 1.3 points at untreated sites. A 2024 study reported better scores after full-body 453 nm exposure in 20 people with atopic dermatitis, but it had no comparison group. These findings apply to the eczema populations studied. Other forms, such as contact dermatitis, need separate evidence. [5] [6]
Plaque psoriasis
In two controlled studies, researchers treated a selected plaque and compared it with an untreated plaque on the same person. One four-week study found lower local severity scores with 420 nm or 453 nm blue light. In a separate 12-week study of 47 people with mild psoriasis, the difference favoring treated plaques was about 0.7 to 0.9 points on the Local Psoriasis Severity Index, depending on the intensity group. [7] [2]
Results have varied across devices and studies. An earlier trial in 17 people found no significant plaque improvement with a fluorescent blue-light source. In 2026, an uncontrolled full-body study in 21 people reported a drop in the mean Psoriasis Area and Severity Index from 11.87 to 6.90. With no comparison group, the full-body study could show that scores fell during the study, while leaving the effect of light itself uncertain. [8] [9]
Treatment schedules and why distance matters
Treatment duration and session structure: what the evidence says
AD-Blue scheduled a follow-up assessment four weeks after the treatment course. When comparing that course with a different study, check how the light was delivered and when researchers measured the result. A session’s length is only one part of the exposure. The amount of light reaching each area of skin also depends on irradiance and device positioning. [1] [10]
Close to a panel or mask, light from several LEDs can overlap at the skin. The inverse-square rule is a point-source approximation. For these devices, use irradiance measured at the intended skin position and operating setting. [10] How irradiance is measured at a working distance
What the inflammation findings can tell us
In AD-Blue, skin biopsies from six participants in the blue-light groups showed lower expression of IL-31, a signaling protein involved in itch, after treatment. The trial found no significant changes in the cytokines it measured in blood or from sampled immune cells. [1]
An experiment on healthy volunteers illustrates why barrier measurements also matter. Researchers irritated forearm skin and measured both inflammation and water loss. A local inflammatory marker rose significantly after tape stripping in the control condition, while the rise in the blue-light condition was statistically inconclusive. The blue-light sites lost more water at 24 hours. The experiment used temporarily irritated healthy skin, so its findings leave eczema barrier repair unresolved. [11]
There are also skin and eye effects to consider. In a study of Fitzpatrick skin types III and IV, 415 nm exposure caused dose-related darkening, with pigmentation lasting up to three months under the conditions tested. Bright blue light can pose a retinal hazard depending on the source and exposure. Follow the device’s eye-protection instructions and tell your clinician if you have photosensitivity or take medication that increases light sensitivity. [12] [13] [1]
Where blue light fits alongside medical phototherapy
Comparing phototherapy types: where blue light fits in the clinical toolkit
| Modality | Where it fits |
|---|---|
| Visible blue LED | Studies discussed here used 415–453 nm. Researchers have examined eczema itch and individual psoriasis plaques, with results that vary by device and outcome. [1] [2] |
| Narrowband UVB, 311–313 nm | NICE recommends it for plaque or guttate psoriasis when topical treatment alone provides insufficient control. European guidance also includes it for moderate-to-severe atopic eczema. [14] [15] [16] |
| 308 nm excimer laser or light | Targeted UVB used for selected areas of localized plaque psoriasis. [16] |
| UVA1 | European guidance includes medium-dose UVA1 as another option for moderate-to-severe atopic eczema. [15] |
| PUVA | UVA combined with psoralen. Clinicians weigh cumulative skin cancer risk when considering it for psoriasis. [14] [16] |
In photodynamic therapy (PDT), light activates a photosensitizing drug. One example is Levulan Kerastick, which pairs aminolevulinic acid with a specific blue-light illuminator to treat certain actinic keratoses. [17]
How to evaluate a blue light device
Choosing a blue light device: what specifications actually matter
- Measured wavelength. Ask for the peak wavelength and spectral bandwidth of the blue channel on the exact model you are evaluating. How REDDOT LED verifies wavelength accuracy
- Irradiance and coverage at the skin. Ask for blue-channel irradiance in mW/cm² at the stated distance or fit. Check the active channels and whether the report gives a center reading or a map across the treatment area. On a mask, the nose, cheeks, and jaw can sit at different distances from the LEDs. [10]
- Controls and safety instructions. Check how the timer and intensity controls work, what eye protection the manufacturer specifies, and which operating modes the safety report covers. [13]
- Intended use in the target market. In the US, the FDA’s 510(k) record for Philips BlueControl identifies it as a prescription home-use device for adults with mild psoriasis vulgaris. That clearance applies to the specific device and indication. Establishment registration and device listing serve a separate purpose. [18] [19]
REDDOT LED’s CS-001 3D Mask page lists a 460 nm blue channel. The F2 Aurora Butterfly is a separate model with its own optical configuration. The controlled eczema and psoriasis studies above used other devices and blue wavelengths of 415–453 nm. [1] [2] CS-001 specifications · F2 specifications
Key takeaways
If you’re discussing phototherapy with a dermatologist, bring a list of your medicines and describe the problem you want to address, such as nighttime itch or a persistent plaque. Ask what improvement would count, how it will be measured, and when you’ll review your response.
FAQ
Can I use a cosmetic blue LED mask for an eczema flare?
Ask your dermatologist to assess the rash and review the mask’s intended use before you put it on affected skin. Bring the model name and instructions. The eczema studies used purpose-built equipment for either full-body exposure or treatment of selected patches. [1] [5]
Is blue light more effective than red light for psoriasis?
A pilot study in 20 people compared blue and red light on selected plaques. Participants also used salicylic acid to remove scale. Redness continued to improve in the plaques treated with blue light. The red device delivered lower irradiance, so the trial gives limited information about the effect of wavelength alone. [20]
How long does narrowband UVB take to work for psoriasis?
The American Academy of Dermatology describes a typical course as several weeks of repeated visits. NICE says two or three sessions a week can be offered and that three may produce a quicker response. Your clinician sets the schedule and adjusts it based on how your skin responds. [21] [14]
Can narrowband UVB be prescribed for home use?
Yes, for some people with psoriasis. In the 783-person LITE trial, home narrowband UVB using a device with guided dosing performed comparably to office treatment on patient- and clinician-reported outcomes. A dermatologist can advise on eligibility, the equipment, and follow-up. [22]
Related guides
Related Guides
- Blue light therapy basics
- How factories verify LED wavelength accuracy
- How to evaluate light therapy devices and their claims
References
- Buhl T, et al. (2023). Full-body blue light irradiation as treatment for atopic dermatitis. Randomized sham-controlled AD-Blue trial. Journal der Deutschen Dermatologischen Gesellschaft. Full text · PubMed
- Pfaff S, et al. (2015). Randomized study of UV-free blue light for mild psoriasis vulgaris. Dermatology. PubMed
- Sadowska M, et al. (2021). Blue light in dermatology. Life. Full text
- Plum F, et al. (2026). Systematic review of blue light effects on cultured keratinocytes. Photodiagnosis and Photodynamic Therapy. PubMed
- Keemss K, et al. (2016). Randomized study of local UV-free blue light treatment for eczema. Dermatology. PubMed
- Sadowska M, et al. (2024). Prospective clinical study of full-body blue irradiation for atopic dermatitis. Dermatology and Therapy. Full text
- Weinstabl A, et al. (2011). Prospective randomized study of blue light in psoriasis vulgaris. Dermatology. PubMed
- Maari C, et al. (2003). Repeated exposure to blue light does not improve psoriasis. Journal of the American Academy of Dermatology. PubMed
- Nolberczak D, et al. (2026). Systemic immunomodulatory effects of full-body blue light therapy in psoriasis vulgaris patients. Journal of Clinical Medicine. Full text · PubMed
- Hadis MA, et al. (2016). The dark art of light measurement. Accurate radiometry for low-level light therapy. Lasers in Medical Science. Full text
- Falcone D, et al. (2018). Blue light, inflammation, and skin barrier recovery after experimental irritation. Photodermatology, Photoimmunology & Photomedicine. PubMed
- Duteil L, et al. (2014). Differences in visible-light-induced pigmentation by wavelength. Pigment Cell & Melanoma Research. PubMed
- International Commission on Illumination (2019). Position statement on the blue light hazard
- National Institute for Health and Care Excellence. Psoriasis assessment and management, guideline CG153
- EuroGuiDerm (2025). Atopic eczema guideline, section on phototherapy and photochemotherapy. Guideline PDF
- Elmets CA, et al. (2019). AAD–NPF guidelines for the management and treatment of psoriasis with phototherapy. Journal of the American Academy of Dermatology. PubMed · Phototherapy treatment pathway
- U.S. Food and Drug Administration. Levulan Kerastick and BLU-U prescribing information
- U.S. Food and Drug Administration (2017). Philips BlueControl 510(k) summary, K171055
- U.S. Food and Drug Administration. Important reminders about device registration and listing
- Kleinpenning MM, et al. (2012). Randomized comparison of blue and red light in psoriasis. Journal of the European Academy of Dermatology and Venereology. PubMed
- American Academy of Dermatology. Psoriasis treatment with phototherapy
- Gelfand JM, et al. (2024). Home- vs office-based narrowband UV-B phototherapy for psoriasis. LITE randomized clinical trial. JAMA Dermatology. Full text